Consumer Discretionary • Catalog/Specialty Distribution
$4.94 ▲ +0.00
(0.00%)
MKT CAP: $166.1M • VOL: 133.9K
52W L $3 52W H $7
DIBS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $89.6M | $88.3M | $84.7M |
| YoY Revenue Growth % | +1.5% | +4.2% | — |
| Gross Profit | $65.4M | $63.4M | — |
| Gross Margin % | 73.0% | 71.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$19.0M | -$26.2M | -$31.0M |
| Operating Margin % | -21.2% | -29.7% | -36.6% |
| Net Income (GAAP) | -$13.7M | -$18.6M | -$22.7M |
| EBITDA (Normalized) | -$18.4M | -$24.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.4M | -$2.9M | -$13.6M |
| Capital Expenditures (CapEx) | $763.0K | $1.9M | — |
| Free Cash Flow (FCF) | -$3.2M | -$4.8M | -$13.6M |
| FCF Margin % | -3.6% | -5.5% | -16.0% |
| Return on Invested Capital (ROIC %) | -21.2% | -28.2% | — |
| Cash & Short-Term Equivalents | $22.9M | $26.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $93.6M | $99.3M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR DIBS.